Evidence map›Paper›PMID 34590493›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

D-dimer Level and Diabetes in the COVID-19 Infection.

Chaymae Miri, Hajar Charii, Mohammed-Amine Bouazzaoui, Falmata Laouan Brem, Soumia Boulouiz, Naima Abda, Hatim Kouismi, Zakaria Bazid, Nabila Ismaili, Noha El Ouafi

Open access · goldAbstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. D-dimer, COVID-19 and Diabetes: A Correspondence.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chaymae Miri470522Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.ORCID https://orcid.org/0000-0002-3752-0953
Hajar Charii470522Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.
Mohammed-Amine BouazzaouiMohammed First University, Oujda, Morocco.
Falmata Laouan Brem470522Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.ORCID https://orcid.org/0000-0002-5742-0781
Soumia Boulouiz470522Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.
Naima AbdaMohammed First University, Oujda, Morocco.
Hatim Kouismi470522Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.
Zakaria Bazid470522Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.
Nabila Ismaili470522Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.
Noha El Ouafi470522Mohammed VI University Hospital, Mohammed First University, Oujda, Morocco.
Mohamed I University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDiabetes is the most common of comorbidity in patients with SARS-COV-2 pneumonia. Coagulation abnormalities with D-dimer levels are increased in this disease. OBJECTIFS: We aimed to compare the levels of D-dimer in diabetic and non-diabetic patients with COVID 19. A link between D-dimer and mortality has also been established. MATERIALS: A retrospective study was carried out at the University Hospital Center of Oujda (Morocco) from November 01st to December 01st, 2020. Our study population was divided into two groups: a diabetic group and a second group without diabetes to compare clinical and biological characteristics between the two groups. In addition, the receiver operator characteristic curve was used to assess the optimal D-dimer cut-off point for predicting mortality in diabetics.

results201 confirmed-COVID-19-patients were included in the final analysis. The median age was 64 (IQR 56-73), and 56% were male. Our study found that D-dimer levels were statistically higher in diabetic patients compared to non-diabetic patients. (1745 vs 845 respectively,

conclusionOur study found that diabetics with COVID-19 are likely to develop hypercoagulation with a poor prognosis.

Indexed as

SARS-CoV-2AgedArea Under CurveBiomarkersComorbidityCOVID-19C-Reactive ProteinDiabetes ComplicationsDiabetes MellitusFemaleFibrin Fibrinogen Degradation ProductsHospital MortalityHumansHypertensionInflammationKaplan-Meier EstimateBiomarkersC-Reactive ProteinFibrin Fibrinogen Degradation Productsfibrin fragment DCoagulopathyCOVID-19C-reactive proteinD-dimerDiabetesInflammation

Identifiers

PMID34590493
PMCPMC8495508
OpenAlexW3202354710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.